- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossaryFantasy Share GameResearch ToolsNEX Share PricesShare ChatFinance NewsShare TradingForexMediaBlogsLive PricesShares BookshopFinance ToolsMembers
TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential
Latest Share Chat
Glaxosmithkline Regulatory News (GSK)
Regulatory News for Glaxosmithkline (GSK)
| Share Price: 1,595.40 | Bid: 1,595.20 | Ask: 1,595.40 | Change: 0.20 (+0.01%) |  | ||||||
| ||||||||||
| Date | Source | Headline | Category |
|---|---|---|---|
| 12-Jun-19 17:10 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 07-Jun-19 07:00 | RNS | FDA approval for Nucala self-administration | Company Announcement - General |
| 04-Jun-19 08:00 | RNS | CHMP positive on GSK's Nucala self-administration | Company Announcement - General |
| 03-Jun-19 14:31 | RNS | Total Voting Rights | Holding(s) in Company |
| 24-May-19 10:54 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 20-May-19 13:44 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 13-May-19 17:44 | RNS | Block listing Interim Review | Company Announcement - General |
| 13-May-19 16:19 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 08-May-19 18:23 | RNS | Result of AGM & GM | Results and Trading Reports |
| 02-May-19 17:07 | RNS | Trelegy Ellipta asthma study met primary endpoint | Company Announcement - General |
| 01-May-19 15:11 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 01-May-19 14:32 | RNS | Total Voting Rights | Holding(s) in Company |
| 01-May-19 12:00 | RNS | 1st Quarter Results | Results and Trading Reports |
| 29-Apr-19 12:00 | RNS | ViiV submits NDA for HIV monthly 2 drug injectable | Company Announcement - General |
| 26-Apr-19 16:16 | RNS | ViiV receives CHMP Positive Opinion for Dovato | Company Announcement - General |
| 16-Apr-19 17:36 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 16-Apr-19 17:35 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 16-Apr-19 17:23 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 16-Apr-19 17:14 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 15-Apr-19 14:45 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 12-Apr-19 16:47 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 12-Apr-19 16:33 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 11-Apr-19 17:01 | RNS | Director/PDMR Shareholding | Directors' Dealings |
| 09-Apr-19 07:00 | RNS | FDA approves ViiV's two-drug HIV regimen, Dovato | Company Announcement - General |
| 02-Apr-19 13:00 | RNS | Publication of AGM and GM Shareholder Documents | Company Announcement - General |
| 01-Apr-19 16:36 | RNS | Total Voting Rights | Holding(s) in Company |
| 28-Mar-19 16:15 | RNS | GSK reporting changes - product sales and IFRS 16 | Company Announcement - General |
| 21-Mar-19 16:00 | RNS | GSK announces further positive data from DREAMM-1 | Company Announcement - General |
| 19-Mar-19 17:45 | RNS | Data from GARNET study evaluating dostarlimab | Company Announcement - General |
| 18-Mar-19 07:00 | RNS | GSK Annual Report 2018 on Form 20-F | Company Announcement - General |
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
